Physician profile
Daniel S Berman
NPI 1538296967
$17,417.79
in general payments reported to CMS, 2019-2025
10 companies · $283 in 2025
The $283 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,036 · 2021: $2,885 · 2022: $5,480 · 2023: $655 · 2024: $78.48 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,016.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $12,223.38 | 2019-2022 | |
| Ge Healthcare | $4,099.53 | 2019-2025 | |
| Pfizer INC. | $292.95 | 2019-2024 | |
| Siemens Medical Solutions USA, INC. | $243.35 | 2023-2025 | Somatom Force, Biograph Vision 600 (8 Ring/64 Ct) |
| Abbott Laboratories | $178.64 | 2022 | |
| Heartflow, INC. | $142.88 | 2023 | Ffrct |
| Cleerly, INC. | $98.22 | 2023 | |
| Medtronic, INC. | $85.46 | 2021 | |
| Amgen INC. | $27.00 | 2019 | |
| Canon Medical Systems USA, INC. | $26.38 | 2023 | Interventional Angiography System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.